Structured Summary
Abstract
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
17 entry terms
- Adoptive Cellular Immunotherapy
- Cellular Immunotherapy, Adoptive
- Immunotherapy, Adoptive
- Immunotherapy, Adoptive Cellular
- Adoptive Cellular Immunotherapies
- Adoptive Immunotherapies
- Cellular Immunotherapies, Adoptive
- Immunotherapies, Adoptive
- Immunotherapies, Adoptive Cellular
- CAR T-Cell Therapy
- Chimeric Antigen Receptor Therapy
- CAR T Cell Therapy
- CAR T-Cell Therapies
- T-Cell Therapies, CAR
- T-Cell Therapy, CAR
- Therapies, CAR T-Cell
- Therapy, CAR T-Cell
MeSH Record
Aspects Covered
15 allowable subheadings
Indexed with the subheadings adverse effects, classification, economics, ethics, history, instrumentation, legislation & jurisprudence, methods, mortality, nursing, psychology, standards, statistics & numerical data, trends, veterinary.
MeSH Record
Indexing Annotation
for CAR T-Cell Therapy, coordinate with RECEPTORS, CHIMERIC ANTIGEN
MeSH Record
History Note
1991
MeSH Record
Previous Indexing
- Immunization, Passive (1983-1990)
MeSH Hierarchy
Tree Numbers
MeSH Record
NLM Classification
QW 940
AMA Style
References
- National Library of Medicine. Adoptive Immunotherapy. Medical Subject Headings (MeSH). 2026. Unique ID D016219. http://id.nlm.nih.gov/mesh/2026/D016219
- Adoptive Immunotherapy. In: Wikidata. https://www.wikidata.org/wiki/Q72138716